These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8595575)

  • 21. Is hospitalization after TIA cost-effective on the basis of treatment with tPA?
    Nguyen-Huynh MN; Johnston SC
    Neurology; 2005 Dec; 65(11):1799-801. PubMed ID: 16344525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic agents.
    Thompson PL
    Med J Aust; 1994 Jan; 160(1):29-32. PubMed ID: 8271981
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue plasminogen activator does not benefit most eligible patients with stroke.
    Lansberg MG; Schwartz NE
    Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
    [No Abstract]   [Full Text] [Related]  

  • 25. Stenting versus thrombolysis in acute myocardial infarction trial (STAT).
    Indian Heart J; 2001; 53(3):375. PubMed ID: 11516047
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolysis in newborns and infants.
    Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
    Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute ischemic stroke, Part 1.
    Fullerton T
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):571-2. PubMed ID: 8908931
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombolysis in acute cerebrovascular disease: indications and limitations.
    Hacke W; Ringleb P; Stingele R
    Thromb Haemost; 1999 Aug; 82(2):983-6. PubMed ID: 10605813
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-effectiveness of thrombolytics: a simplified model.
    Apikoğlu Rabuş S; Izzettin FV; Sancar M; Rabuş MB; Kirma C; Yakut C
    Pharm World Sci; 2005 Jun; 27(3):243-8. PubMed ID: 16096895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is alteplase (t-PA) more cost-effective than streptokinase?
    Sanchez LA
    Pharmacoeconomics; 1992 Nov; 2(5):427-8. PubMed ID: 10172065
    [No Abstract]   [Full Text] [Related]  

  • 33. NINDS Reanalysis Committee's reanalysis of the NINDS trial.
    Mann J
    Stroke; 2005 Feb; 36(2):230-1; author reply 230-1. PubMed ID: 15637327
    [No Abstract]   [Full Text] [Related]  

  • 34. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.
    Böttiger BW; Padosch SA; Wenzel V
    N Engl J Med; 2002 Oct; 347(16):1281-2; author reply 1281-2. PubMed ID: 12393830
    [No Abstract]   [Full Text] [Related]  

  • 35. Testing new ideas: is a picture worth a thousand words?
    Yealy DM; Callaham ML
    Ann Emerg Med; 2009 Sep; 54(3):337-8. PubMed ID: 19695416
    [No Abstract]   [Full Text] [Related]  

  • 36. Towards a superior streptokinase for fibrinolytic therapy of vascular thrombosis.
    Keramati M; Mianroodi RA; Memarnejadian A; Mirzaie A; Sazvari S; Aslani MM; Roohvand F
    Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):218-29. PubMed ID: 23531210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic treatment. Streptokinase is more economical than alteplase.
    Mucklow JC
    BMJ; 1995 Dec; 311(7018):1506. PubMed ID: 8520368
    [No Abstract]   [Full Text] [Related]  

  • 38. Study assigns dollar value to alteplase-streptokinase debate.
    Am J Health Syst Pharm; 1995 Aug; 52(15):1600. PubMed ID: 7583819
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue plasminogen activator.
    de Bono DP
    Br J Hosp Med; 1986 Aug; 36(2):87. PubMed ID: 3091129
    [No Abstract]   [Full Text] [Related]  

  • 40. Meta-analysis: is moving the goal post the answer?
    Egger M; Smith GD; Sterne JA
    Lancet; 1998 May; 351(9114):1517. PubMed ID: 9605838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.